Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: A randomized controlled trial

Journal of Chinese Integrative Medicine

Volumn 7, Issue 11, 2009, Pages 1047-1051

  Huang, Jing Yu ^a   Sun, Yan ^a   Fan, Qing Xia ^a   Zhang, Yu Qing ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chemotherapy; Esophageal cancer; Randomized controlled trial; Shenyi Capsule

Indexed keywords

CHINESE DRUG; CISPLATIN; GEMCITABINE; SHENYI; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROCAPSULE; MONOTHERAPY; NAUSEA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE; TREATMENT RESPONSE; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAPSULES; CISPLATIN; DEOXYCYTIDINE; ESOPHAGEAL NEOPLASMS; FEMALE; GINSENOSIDES; HUMANS; MALE; MIDDLE AGED; PANAX; PHYTOTHERAPY; QUALITY OF LIFE; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73949087913     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20091105     Document Type: Article

References (10)

1. Sun Y, Shi YK. Manual of medical oncology. Beijing: People's Medical Publishing House. 2007: 467-469. Chinese.
2. Sun Y. Medical oncology. Beijing: People's Medical Publishing House. 2003: 994. Chinese.
3. Lin JJ, Zeng YJ, Ma ZL. Clinical significance of serum vascular endothelial growth factor in lung carcinoma. You Jiang Yi Xue. 2005; 33(2): 116-117. Chinese with abstract in English.
4. Zhou JC. Practical medical oncology. Beijing: People's Medical Publishing House. 2003: 33-35. Chinese.
5. Kroep JR, Pinedo HM, Ginccone G, Van Bochove A, Peters GJ, Van Groeningen CJ. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Ann Oncol. 2004; 15(2): 230-235.
6. Urba SG, Chansky K, Vanveldhuien PJ, Pluenneke RE, Benedetti JK, Macdonald JS, Abbruzzese JL; Southwest Oncology Group Study. Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study. Invest New Drugs. 2004; 22(1): 91-97.
7. Wang JS, Qin SK, Chen YX, Wang L, Liu XF, He ZM. Clinical study on qi deficiency patients with non-small cell lung cancer (NSCLC) treated by Shenyi capsule. Lin Chuang Zhong Liu Xue Za Zhi. 2001; 6(4): 327-331. Chinese.
8. Lu PC, Zhan Z, Zhou KF, Chen JW. Effects of ginseng and ginseng combined with TNF on tumor animal. Nanjing Zhong Yi Yao Da Xue Xue Bao. 1997; 13(60): 344-346. Chinese.
9. Liu JW, Chen JX, Yu LH, Tian YX, Cui XY, Yan Q, Fu L. Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor. Zhonghua Zhong Liu Za Zhi. 2004; 26 (12): 722-725. Chinese with abstract in English.
10. Hua HQ, Shen XK, Qin SK, Chen HY. Anti-invasion and anti-metastasis effects of ginsenoside Rg3 on the hepatocellular carcinoma cell line. Zhongguo Ai Zheng Za Zhi. 2005; 15(4): 326-330. Chinese with abstract in English.